Symbols / TRVN $0.01 +0.00% Trevena, Inc.

Healthcare • Biotechnology • United States • PNK
TRVN Chart
About

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 9.50K
Enterprise Value 24.11M Income -34.04M Sales 546.00K
Book/sh -27.27 Cash/sh 15.59 Dividend Yield —
Payout 0.00% Employees 23 IPO —
P/E — Forward P/E -0.00 PEG —
P/S 0.02 P/B -0.00 P/C —
EV/EBITDA -0.76 EV/Sales 44.16 Quick Ratio 2.21
Current Ratio 2.42 Debt/Eq — LT Debt/Eq —
EPS (ttm) -48.89 EPS next Y -19.85 EPS Growth —
Revenue Growth 57.20% Earnings 2024-11-07 07:00 ROA -62.39%
ROE — ROIC — Gross Margin -190.48%
Oper. Margin -19.71% Profit Margin 0.00% Shs Outstand 863.79K
Shs Float 858.69K Short Float 7.03% Short Ratio 1.00
Short Interest — 52W High 1.38 52W Low 0.00
Beta 0.60 Avg Volume 258.00 Volume 210.00
Target Price — Recom None Prev Close $0.01
Price $0.01 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.01
Latest analyst target
3. DCF / Fair value
$-350.58
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.01
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-11-14 down HC Wainwright & Co. Buy → Neutral $5
2024-05-16 main HC Wainwright & Co. Buy → Buy $5
2024-04-02 main HC Wainwright & Co. Buy → Buy $9
2024-03-11 reit HC Wainwright & Co. Buy → Buy $9
2023-05-17 reit JMP Securities Market Outperform → Market Outperform $2
2023-03-31 reit JMP Securities — → Market Outperform $2
2023-03-31 reit HC Wainwright & Co. — → Buy $9
News
RSS: Latest TRVN news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Revenue
3.12
+847.61%
-0.42
-173.72%
0.57
Operating Revenue
3.12
+847.61%
-0.42
-173.72%
0.57
Cost Of Revenue
1.67
-44.67%
3.02
+216.35%
0.95
Reconciled Cost Of Revenue
1.67
-44.67%
3.02
+216.35%
0.95
Gross Profit
1.46
+142.35%
-3.44
-787.86%
-0.39
Operating Expense
36.74
-30.59%
52.94
+2.72%
51.54
Research And Development
16.33
-10.31%
18.21
+35.64%
13.43
Selling General And Administration
20.41
-41.23%
34.73
-8.88%
38.11
General And Administrative Expense
—
—
38.11
Other Gand A
—
—
38.11
Total Expenses
38.41
-31.35%
55.96
+6.60%
52.49
Operating Income
-35.29
+37.40%
-56.38
-8.57%
-51.92
Total Operating Income As Reported
-35.29
+37.40%
-56.38
-8.57%
-51.92
EBITDA
-35.99
+30.83%
-52.03
-1.71%
-51.16
Normalized EBITDA
-38.08
+39.77%
-63.22
-23.57%
-51.16
Reconciled Depreciation
0.33
-12.57%
0.38
-10.75%
0.43
EBIT
-36.33
+30.69%
-52.41
-1.60%
-51.59
Total Unusual Items
2.08
-81.37%
11.19
+279675.00%
0.00
Total Unusual Items Excluding Goodwill
2.08
-81.37%
11.19
+279675.00%
0.00
Net Income
-40.29
+24.93%
-53.67
-4.04%
-51.59
Pretax Income
-39.97
+25.52%
-53.67
-4.04%
-51.59
Net Non Operating Interest Income Expense
-2.25
-179.01%
-0.81
-600.00%
0.16
Interest Expense Non Operating
3.64
+190.13%
1.26
+125500.00%
0.00
Net Interest Income
-2.25
-179.01%
-0.81
-600.00%
0.16
Interest Expense
3.64
+190.13%
1.26
+125500.00%
0.00
Interest Income Non Operating
1.40
+209.98%
0.45
+178.40%
0.16
Interest Income
1.40
+209.98%
0.45
+178.40%
0.16
Other Income Expense
-2.44
-169.43%
3.51
+1894.32%
0.18
Other Non Operating Income Expenses
-4.52
+41.13%
-7.68
-4565.70%
0.17
Gain On Sale Of Security
2.08
-81.37%
11.19
+279675.00%
0.00
Tax Provision
0.32
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.44
0.00
0.00
Net Income Including Noncontrolling Interests
-40.29
+24.93%
-53.67
-4.04%
-51.59
Net Income From Continuing Operation Net Minority Interest
-40.29
+24.93%
-53.67
-4.04%
-51.59
Net Income From Continuing And Discontinued Operation
-40.29
+24.93%
-53.67
-4.04%
-51.59
Net Income Continuous Operations
-40.29
+24.93%
-53.67
-4.04%
-51.59
Normalized Income
-41.94
+35.34%
-64.86
-25.72%
-51.59
Net Income Common Stockholders
-40.29
+24.93%
-53.67
-4.04%
-51.59
Diluted EPS
-79.00
+58.37%
-189.75
+5.13%
-200.00
Basic EPS
-79.00
+58.37%
-189.75
+5.13%
-200.00
Basic Average Shares
0.51
+80.07%
0.28
+8.28%
0.26
Diluted Average Shares
0.51
+80.07%
0.28
+8.28%
0.26
Diluted NI Availto Com Stockholders
-40.29
+24.93%
-53.67
-4.04%
-51.59
Line Item Trend 2023-12-31
Total Assets
40.60
Current Assets
35.20
Cash Cash Equivalents And Short Term Investments
32.98
Cash And Cash Equivalents
32.98
Cash Equivalents
29.82
Cash Financial
3.16
Receivables
—
Accounts Receivable
—
Inventory
0.00
Finished Goods
0.00
Prepaid Assets
—
Other Current Assets
2.23
Total Non Current Assets
5.40
Net PPE
4.86
Gross PPE
7.46
Accumulated Depreciation
-2.60
Properties
0.00
Machinery Furniture Equipment
0.67
Other Properties
3.70
Leases
3.08
Other Non Current Assets
0.54
Total Liabilities Net Minority Interest
48.26
Current Liabilities
7.55
Payables And Accrued Expenses
4.45
Payables
2.30
Accounts Payable
2.30
Current Accrued Expenses
2.15
Pensionand Other Post Retirement Benefit Plans Current
2.09
Current Debt And Capital Lease Obligation
1.01
Current Capital Lease Obligation
1.01
Total Non Current Liabilities Net Minority Interest
40.71
Long Term Debt And Capital Lease Obligation
35.23
Long Term Debt
30.81
Long Term Capital Lease Obligation
4.42
Stockholders Equity
-7.66
Common Stock Equity
-7.66
Capital Stock
0.02
Common Stock
0.02
Preferred Stock
0.00
Share Issued
0.69
Ordinary Shares Number
0.69
Treasury Shares Number
0.00
Additional Paid In Capital
580.39
Retained Earnings
-588.06
Gains Losses Not Affecting Retained Earnings
0.00
Other Equity Adjustments
—
Total Equity Gross Minority Interest
-7.66
Total Capitalization
23.15
Working Capital
27.65
Invested Capital
23.15
Total Debt
36.24
Capital Lease Obligations
5.44
Net Tangible Assets
-7.66
Tangible Book Value
-7.66
Derivative Product Liabilities
5.47
Interest Payable
0.00
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-33.03
+35.83%
-51.48
-2.55%
-50.20
Cash Flow From Continuing Operating Activities
-33.03
+35.83%
-51.48
-2.55%
-50.20
Net Income From Continuing Operations
-40.29
+24.93%
-53.67
-4.04%
-51.59
Depreciation Amortization Depletion
0.33
-12.57%
0.38
-10.75%
0.43
Depreciation
0.33
-12.57%
0.38
-10.75%
0.43
Depreciation And Amortization
0.33
-12.57%
0.38
-10.75%
0.43
Other Non Cash Items
3.20
+4.34%
3.06
+641.65%
0.41
Stock Based Compensation
2.93
-20.29%
3.68
-16.59%
4.41
Operating Gains Losses
2.55
+163.18%
-4.03
-67116.67%
-0.01
Gain Loss On Investment Securities
2.55
+163.18%
-4.03
-67116.67%
-0.01
Change In Working Capital
-1.75
-106.60%
-0.85
+77.95%
-3.85
Change In Receivables
0.52
-56.82%
1.21
+151.73%
-2.34
Changes In Account Receivables
0.52
-56.82%
1.21
+151.73%
-2.34
Change In Inventory
0.01
+101.60%
-0.62
+73.47%
-2.35
Change In Prepaid Assets
—
1.21
+151.73%
-2.34
Change In Payables And Accrued Expense
-1.40
-106.95%
-0.68
-144.10%
1.53
Change In Other Current Assets
—
0.00
-100.00%
9.00
Change In Other Current Liabilities
-0.89
-17.02%
-0.76
+92.18%
-9.70
Investing Cash Flow
-0.04
-327.78%
0.02
+212.50%
-0.02
Cash Flow From Continuing Investing Activities
-0.04
-327.78%
0.02
+212.50%
-0.02
Net PPE Purchase And Sale
-0.04
-46.43%
-0.03
-75.00%
-0.02
Purchase Of PPE
-0.04
-46.43%
-0.03
-75.00%
-0.02
Capital Expenditure
-0.04
-46.43%
-0.03
-75.00%
-0.02
Net Investment Purchase And Sale
0.00
-100.00%
0.05
0.00
Purchase Of Investment
0.00
+100.00%
-32.95
0.00
Sale Of Investment
0.00
-100.00%
33.00
0.00
Financing Cash Flow
26.31
+11.94%
23.50
+203.92%
7.73
Cash Flow From Continuing Financing Activities
26.31
+11.94%
23.50
+203.92%
7.73
Net Issuance Payments Of Debt
14.76
+6.22%
13.90
+173825.00%
-0.01
Issuance Of Debt
14.78
+6.25%
13.91
0.00
Repayment Of Debt
-0.01
-50.00%
-0.01
+0.00%
-0.01
Long Term Debt Issuance
14.78
+6.25%
13.91
0.00
Long Term Debt Payments
-0.01
-50.00%
-0.01
+0.00%
-0.01
Net Long Term Debt Issuance
14.76
+6.22%
13.90
+173825.00%
-0.01
Net Common Stock Issuance
9.49
+18.69%
8.00
+0.62%
7.95
Proceeds From Stock Option Exercised
2.06
0.00
-100.00%
0.19
Net Other Financing Charges
-0.00
+94.59%
-0.04
+90.59%
-0.39
Changes In Cash
-6.76
+75.80%
-27.95
+34.19%
-42.48
Beginning Cash Position
40.28
-40.97%
68.23
-38.37%
110.71
End Cash Position
33.52
-16.79%
40.28
-40.97%
68.23
Free Cash Flow
-33.08
+35.78%
-51.51
-2.57%
-50.21
Interest Paid Supplemental Data
0.80
+32.62%
0.60
0.00
Amortization Of Securities
0.00
+100.00%
-0.05
0.00
Common Stock Issuance
9.49
+18.69%
8.00
+0.62%
7.95
Issuance Of Capital Stock
9.49
-1.58%
9.64
+21.34%
7.95
Net Preferred Stock Issuance
0.00
-100.00%
1.65
0.00
Preferred Stock Issuance
0.00
-100.00%
1.65
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category